State Of Wyoming Genmab A/S Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $6,868 - $9,873	-256 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $464 - $595	-15 Reduced 5.54%	256 $9,000
Q4 2021 Feb 11, 2022	BUY	$35.87 - $47.12 $1,111 - $1,460	31 Added 12.92%	271 $11,000
Q3 2021 Feb 11, 2022	SELL	$41.55 - $48.72 $6,980 - $8,184	-168 Reduced 41.18%	240 $10,000
Q2 2021 Feb 11, 2022	BUY	$32.88 - $44.57 $13,415 - $18,184	408 New	408 $17,000

232

48.5M

6.8K

27.6K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $16B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.